unknown
Stage
About
Develops a novel base editor and advances gene editing technologies aimed at treating genetic disorders, including ocular conditions. The company operates locations in Shanghai, China and Moraga, California.
Explore Base Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.